Navigation path

#679 The European Partnership for Alternative Approaches to Animal Testing (EPAA) Accelerating the Transition to Animal-Free, Sustainable Innovat
New data supporting recognition of evident toxicity in Acute Oral toxicity studies (OECD TG 420)
Re-evaluating the need for chronic toxicity studies with therapeutic monoclonal antibodies, using a weight of evidence approach
Characterization of Hepatic 3D Spheroids Using Multiphoton Microscopy and OMICS
The future of pyrogenicity testing: phasing out the rabbit pyrogen test
EPAA Annual Conference 2022: PRESENTATIONS
EPAA Annual Report 2022
Keynote I “The Importance of: Innovation, Collaboration and Partnerships” by Patrick Masscheleyn
2020 at a glance: EPAA achievements and new Action Programme by Rob Roggeband
Keynote II “3Rs Milestones and challenges ahead” by Judy MacArthur Clark
Mirror Group perspective by Marina Pereira
2020 EPAA Science Prize: “Human mini-hearts from stem cells to study cardiac disease, cardiotoxicity and to reduce animal experiments” by Dr. Viviana Meraviglia
National 3Rs centers perspective, by Adrian Smith
Global perspective by Anna Lowit
15 years of public-private partnership: EPAA achievements
EPAA Publications 2020
Action Programme 2021-2025 adopted 23 Sept 2020
2019 report on the statistics on the use of animals for scientific purposes in the Member States of the European Union in 2015-2017
REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL on the implementation of Directive 2010/63/EU on the protection of animals used for scientific purposes in the Member States of the European Union
EPAA Annual Conference 2019 Report
Partners Forum 2019 - flash report
EPAA privacy statement on the PROTECTION OF YOUR PERSONAL DATA
EPAA Annual Report 2019
The Mirror Group Perspective
Predicting the Carcinogenic Potential of Agrochemicals
Rezultātu skaits lapā: 5 10 15 20 25 | Lappuse 1 no 3

Additional tools

Esiet informēti